Research Status and Progress on Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma in Hebei Province
Esophageal squamous cell carcinoma (ESCC) is one of the most prevalent gastrointestinal cancers in Hebei province. Most patients are diagnosed at an advanced stage due to untypical early symptoms, making surgical treatment often unfeasible. As a result, most of them are treated with comprehensive me...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Magazine House of Cancer Research on Prevention and Treatment
2025-02-01
|
| Series: | Zhongliu Fangzhi Yanjiu |
| Subjects: | |
| Online Access: | http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.24.0856 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850078275917840384 |
|---|---|
| author | Xiaoyang DUAN Jian SHI |
| author_facet | Xiaoyang DUAN Jian SHI |
| author_sort | Xiaoyang DUAN |
| collection | DOAJ |
| description | Esophageal squamous cell carcinoma (ESCC) is one of the most prevalent gastrointestinal cancers in Hebei province. Most patients are diagnosed at an advanced stage due to untypical early symptoms, making surgical treatment often unfeasible. As a result, most of them are treated with comprehensive medical treatment, which tends to have limited effectiveness and poor prognosis. However, the recent introduction of immunotherapy has considerably advanced treatment options for patients with advanced ESCC, notably improving their prognosis. Uncertainties regarding immune resistance, the selection of predictive indicators of efficacy, the identification of dominant population, and the choice of combined treatment strategies are still evident. Therefore, based on the high incidence and poor prognosis of ESCC in Hebei Province, this article will briefly review the research progress in the treatment of advanced ESCC, aiming to provide guidance for treatment strategies for advanced esophageal cancer. |
| format | Article |
| id | doaj-art-6fc50a5954ed458b95d9afaa112ef845 |
| institution | DOAJ |
| issn | 1000-8578 |
| language | zho |
| publishDate | 2025-02-01 |
| publisher | Magazine House of Cancer Research on Prevention and Treatment |
| record_format | Article |
| series | Zhongliu Fangzhi Yanjiu |
| spelling | doaj-art-6fc50a5954ed458b95d9afaa112ef8452025-08-20T02:45:37ZzhoMagazine House of Cancer Research on Prevention and TreatmentZhongliu Fangzhi Yanjiu1000-85782025-02-0152210310910.3971/j.issn.1000-8578.2025.24.085620240856Research Status and Progress on Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma in Hebei ProvinceXiaoyang DUAN0Jian SHI1Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, ChinaDepartment of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, ChinaEsophageal squamous cell carcinoma (ESCC) is one of the most prevalent gastrointestinal cancers in Hebei province. Most patients are diagnosed at an advanced stage due to untypical early symptoms, making surgical treatment often unfeasible. As a result, most of them are treated with comprehensive medical treatment, which tends to have limited effectiveness and poor prognosis. However, the recent introduction of immunotherapy has considerably advanced treatment options for patients with advanced ESCC, notably improving their prognosis. Uncertainties regarding immune resistance, the selection of predictive indicators of efficacy, the identification of dominant population, and the choice of combined treatment strategies are still evident. Therefore, based on the high incidence and poor prognosis of ESCC in Hebei Province, this article will briefly review the research progress in the treatment of advanced ESCC, aiming to provide guidance for treatment strategies for advanced esophageal cancer.http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.24.0856esophageal squamous cell carcinomaimmunotherapyresearch progress |
| spellingShingle | Xiaoyang DUAN Jian SHI Research Status and Progress on Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma in Hebei Province Zhongliu Fangzhi Yanjiu esophageal squamous cell carcinoma immunotherapy research progress |
| title | Research Status and Progress on Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma in Hebei Province |
| title_full | Research Status and Progress on Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma in Hebei Province |
| title_fullStr | Research Status and Progress on Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma in Hebei Province |
| title_full_unstemmed | Research Status and Progress on Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma in Hebei Province |
| title_short | Research Status and Progress on Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma in Hebei Province |
| title_sort | research status and progress on immunotherapy for advanced esophageal squamous cell carcinoma in hebei province |
| topic | esophageal squamous cell carcinoma immunotherapy research progress |
| url | http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.24.0856 |
| work_keys_str_mv | AT xiaoyangduan researchstatusandprogressonimmunotherapyforadvancedesophagealsquamouscellcarcinomainhebeiprovince AT jianshi researchstatusandprogressonimmunotherapyforadvancedesophagealsquamouscellcarcinomainhebeiprovince |